Incannex Healthcare Inc.

IXHL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001873875

SEC filings (opens in a new tab)

No open-market purchases or sales by Incannex Healthcare Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.71M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Incannex Healthcare Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of IXHL: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Q2 2023	Change
Holders	2	2	0
Shares	20.0K	11.7K	−8.32K (−41.5%)
Value	$44.2K	$21.5K	−$22.7K (−51.3%)

New holders (1)

Institutions that held Incannex Healthcare Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to IXHL in Q2 2023
Institution	Shares	Value	% of portfolio
Rhumbline Advisers	55	$100	0.00%

Sold out (1)

Institutions that held Incannex Healthcare Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of IXHL in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Morgan Stanley	2,738	$6.04K